ID   M3K12_HUMAN             Reviewed;         859 AA.
AC   Q12852; B3KSS9; G3V1Y2; Q86VQ5; Q8WY25;
DT   26-SEP-2001, integrated into UniProtKB/Swiss-Prot.
DT   17-OCT-2006, sequence version 2.
DT   12-OCT-2022, entry version 200.
DE   RecName: Full=Mitogen-activated protein kinase kinase kinase 12;
DE            EC=2.7.11.25 {ECO:0000250|UniProtKB:Q60700};
DE   AltName: Full=Dual leucine zipper bearing kinase;
DE            Short=DLK;
DE   AltName: Full=Leucine-zipper protein kinase;
DE            Short=ZPK;
DE   AltName: Full=MAPK-upstream kinase;
DE            Short=MUK;
DE   AltName: Full=Mixed lineage kinase;
GN   Name=MAP3K12; Synonyms=ZPK;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND TISSUE SPECIFICITY.
RC   TISSUE=Teratocarcinoma;
RX   PubMed=8037767; DOI=10.1006/bbrc.1994.1972;
RA   Reddy U.R., Pleasure D.;
RT   "Cloning of a novel putative protein kinase having a leucine zipper domain
RT   from human brain.";
RL   Biochem. Biophys. Res. Commun. 202:613-620(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=14697235; DOI=10.1016/j.bbrc.2003.11.152;
RA   Itoh A., Wang Z., Ito Y., Reddy U.R., Itoh T.;
RT   "SP3 acts as a positive regulator on the core promoter of human ZPK gene.";
RL   Biochem. Biophys. Res. Commun. 313:612-618(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16541075; DOI=10.1038/nature04569;
RA   Scherer S.E., Muzny D.M., Buhay C.J., Chen R., Cree A., Ding Y.,
RA   Dugan-Rocha S., Gill R., Gunaratne P., Harris R.A., Hawes A.C.,
RA   Hernandez J., Hodgson A.V., Hume J., Jackson A., Khan Z.M., Kovar-Smith C.,
RA   Lewis L.R., Lozado R.J., Metzker M.L., Milosavljevic A., Miner G.R.,
RA   Montgomery K.T., Morgan M.B., Nazareth L.V., Scott G., Sodergren E.,
RA   Song X.-Z., Steffen D., Lovering R.C., Wheeler D.A., Worley K.C., Yuan Y.,
RA   Zhang Z., Adams C.Q., Ansari-Lari M.A., Ayele M., Brown M.J., Chen G.,
RA   Chen Z., Clerc-Blankenburg K.P., Davis C., Delgado O., Dinh H.H.,
RA   Draper H., Gonzalez-Garay M.L., Havlak P., Jackson L.R., Jacob L.S.,
RA   Kelly S.H., Li L., Li Z., Liu J., Liu W., Lu J., Maheshwari M.,
RA   Nguyen B.-V., Okwuonu G.O., Pasternak S., Perez L.M., Plopper F.J.H.,
RA   Santibanez J., Shen H., Tabor P.E., Verduzco D., Waldron L., Wang Q.,
RA   Williams G.A., Zhang J., Zhou J., Allen C.C., Amin A.G., Anyalebechi V.,
RA   Bailey M., Barbaria J.A., Bimage K.E., Bryant N.P., Burch P.E.,
RA   Burkett C.E., Burrell K.L., Calderon E., Cardenas V., Carter K., Casias K.,
RA   Cavazos I., Cavazos S.R., Ceasar H., Chacko J., Chan S.N., Chavez D.,
RA   Christopoulos C., Chu J., Cockrell R., Cox C.D., Dang M., Dathorne S.R.,
RA   David R., Davis C.M., Davy-Carroll L., Deshazo D.R., Donlin J.E.,
RA   D'Souza L., Eaves K.A., Egan A., Emery-Cohen A.J., Escotto M., Flagg N.,
RA   Forbes L.D., Gabisi A.M., Garza M., Hamilton C., Henderson N.,
RA   Hernandez O., Hines S., Hogues M.E., Huang M., Idlebird D.G., Johnson R.,
RA   Jolivet A., Jones S., Kagan R., King L.M., Leal B., Lebow H., Lee S.,
RA   LeVan J.M., Lewis L.C., London P., Lorensuhewa L.M., Loulseged H.,
RA   Lovett D.A., Lucier A., Lucier R.L., Ma J., Madu R.C., Mapua P.,
RA   Martindale A.D., Martinez E., Massey E., Mawhiney S., Meador M.G.,
RA   Mendez S., Mercado C., Mercado I.C., Merritt C.E., Miner Z.L., Minja E.,
RA   Mitchell T., Mohabbat F., Mohabbat K., Montgomery B., Moore N., Morris S.,
RA   Munidasa M., Ngo R.N., Nguyen N.B., Nickerson E., Nwaokelemeh O.O.,
RA   Nwokenkwo S., Obregon M., Oguh M., Oragunye N., Oviedo R.J., Parish B.J.,
RA   Parker D.N., Parrish J., Parks K.L., Paul H.A., Payton B.A., Perez A.,
RA   Perrin W., Pickens A., Primus E.L., Pu L.-L., Puazo M., Quiles M.M.,
RA   Quiroz J.B., Rabata D., Reeves K., Ruiz S.J., Shao H., Sisson I.,
RA   Sonaike T., Sorelle R.P., Sutton A.E., Svatek A.F., Svetz L.A.,
RA   Tamerisa K.S., Taylor T.R., Teague B., Thomas N., Thorn R.D., Trejos Z.Y.,
RA   Trevino B.K., Ukegbu O.N., Urban J.B., Vasquez L.I., Vera V.A.,
RA   Villasana D.M., Wang L., Ward-Moore S., Warren J.T., Wei X., White F.,
RA   Williamson A.L., Wleczyk R., Wooden H.S., Wooden S.H., Yen J., Yoon L.,
RA   Yoon V., Zorrilla S.E., Nelson D., Kucherlapati R., Weinstock G.,
RA   Gibbs R.A.;
RT   "The finished DNA sequence of human chromosome 12.";
RL   Nature 440:346-351(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   INTERACTION WITH MBIP, AND DOMAIN.
RX   PubMed=10801814; DOI=10.1074/jbc.m001488200;
RA   Fukuyama K., Yoshida M., Yamashita A., Deyama T., Baba M., Suzuki A.,
RA   Mohri H., Ikezawa Z., Nakajima H., Hirai S., Ohno S.;
RT   "MAPK upstream kinase (MUK)-binding inhibitory protein, a negative
RT   regulator of MUK/Dual leucine zipper-bearing kinase/leucine zipper protein
RT   kinase.";
RL   J. Biol. Chem. 275:21247-21254(2000).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19369195; DOI=10.1074/mcp.m800588-mcp200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [10]
RP   FUNCTION, AND PTM.
RX   PubMed=28111074; DOI=10.1016/j.cell.2016.12.044;
RA   Huang Y.A., Zhou B., Wernig M., Suedhof T.C.;
RT   "ApoE2, ApoE3, and ApoE4 Differentially Stimulate APP Transcription and
RT   Abeta Secretion.";
RL   Cell 168:427-441(2017).
RN   [11]
RP   VARIANTS [LARGE SCALE ANALYSIS] LYS-409; ARG-628 AND SER-640.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C., Bignell G.,
RA   Davies H., Teague J., Butler A., Stevens C., Edkins S., O'Meara S.,
RA   Vastrik I., Schmidt E.E., Avis T., Barthorpe S., Bhamra G., Buck G.,
RA   Choudhury B., Clements J., Cole J., Dicks E., Forbes S., Gray K.,
RA   Halliday K., Harrison R., Hills K., Hinton J., Jenkinson A., Jones D.,
RA   Menzies A., Mironenko T., Perry J., Raine K., Richardson D., Shepherd R.,
RA   Small A., Tofts C., Varian J., Webb T., West S., Widaa S., Yates A.,
RA   Cahill D.P., Louis D.N., Goldstraw P., Nicholson A.G., Brasseur F.,
RA   Looijenga L., Weber B.L., Chiew Y.-E., DeFazio A., Greaves M.F.,
RA   Green A.R., Campbell P., Birney E., Easton D.F., Chenevix-Trench G.,
RA   Tan M.-H., Khoo S.K., Teh B.T., Yuen S.T., Leung S.Y., Wooster R.,
RA   Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Part of a non-canonical MAPK signaling pathway
CC       (PubMed:28111074). Activated by APOE, enhances the AP-1-mediated
CC       transcription of APP, via a MAP kinase signal transduction pathway
CC       composed of MAP2K7 and MAPK1/ERK2 and MAPK3/ERK1 (PubMed:28111074). May
CC       be an activator of the JNK/SAPK pathway. {ECO:0000269|PubMed:28111074}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-
CC         [protein]; Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-
CC         COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.25;
CC         Evidence={ECO:0000250|UniProtKB:Q60700};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-
CC         threonyl-[protein]; Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060,
CC         Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216;
CC         EC=2.7.11.25; Evidence={ECO:0000250|UniProtKB:Q60700};
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC   -!- SUBUNIT: Homodimer (By similarity). Interacts with MBIP
CC       (PubMed:10801814). {ECO:0000250|UniProtKB:Q60700,
CC       ECO:0000269|PubMed:10801814}.
CC   -!- INTERACTION:
CC       Q12852; P00533: EGFR; NbExp=3; IntAct=EBI-710223, EBI-297353;
CC       Q12852; Q70Z53: FRA10AC1; NbExp=2; IntAct=EBI-710223, EBI-710176;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:Q60700}. Cell
CC       membrane {ECO:0000250|UniProtKB:Q60700}. Note=Behaves essentially as an
CC       integral membrane protein. {ECO:0000250|UniProtKB:Q60700}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q12852-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q12852-2; Sequence=VSP_044646;
CC   -!- TISSUE SPECIFICITY: Highly expressed in brain and kidney.
CC       {ECO:0000269|PubMed:8037767}.
CC   -!- DOMAIN: Interacts with MBIP through the leucine-zipper motif.
CC       {ECO:0000269|PubMed:10801814}.
CC   -!- PTM: Autophosphorylated on Ser/Thr. Phosphorylated in cytosol under
CC       basal conditions and dephosphorylated when membrane-associated (By
CC       similarity). {ECO:0000250|UniProtKB:Q60700}.
CC   -!- PTM: The activity of MAP3K12 can be regulated through its proteasomal
CC       degradation. APOE, through a receptor-mediated mechanism, activates
CC       MAP3K12 by preventing its proteasomal degradation.
CC       {ECO:0000269|PubMed:28111074}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. STE Ser/Thr
CC       protein kinase family. MAP kinase kinase kinase subfamily.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U07358; AAA67343.1; -; mRNA.
DR   EMBL; AF283475; AAL67158.1; -; Genomic_DNA.
DR   EMBL; AK094195; BAG52841.1; -; mRNA.
DR   EMBL; AC023509; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471054; EAW96715.1; -; Genomic_DNA.
DR   EMBL; BC050050; AAH50050.1; ALT_SEQ; mRNA.
DR   CCDS; CCDS55831.1; -. [Q12852-2]
DR   CCDS; CCDS8860.1; -. [Q12852-1]
DR   PIR; JC2363; JC2363.
DR   RefSeq; NP_001180440.1; NM_001193511.1. [Q12852-2]
DR   RefSeq; NP_006292.3; NM_006301.3. [Q12852-1]
DR   RefSeq; XP_005269195.1; XM_005269138.3. [Q12852-2]
DR   RefSeq; XP_006719651.1; XM_006719588.3. [Q12852-2]
DR   RefSeq; XP_011537027.1; XM_011538725.2. [Q12852-2]
DR   RefSeq; XP_016875445.1; XM_017019956.1. [Q12852-1]
DR   PDB; 5CEN; X-ray; 1.70 A; A=115-402.
DR   PDB; 5CEO; X-ray; 2.28 A; A=115-402.
DR   PDB; 5CEP; X-ray; 1.99 A; A=115-402.
DR   PDB; 5CEQ; X-ray; 1.91 A; A=115-402.
DR   PDB; 5VO1; X-ray; 2.45 A; A=115-402.
DR   PDB; 5VO2; X-ray; 2.96 A; A=115-402.
DR   PDBsum; 5CEN; -.
DR   PDBsum; 5CEO; -.
DR   PDBsum; 5CEP; -.
DR   PDBsum; 5CEQ; -.
DR   PDBsum; 5VO1; -.
DR   PDBsum; 5VO2; -.
DR   AlphaFoldDB; Q12852; -.
DR   SMR; Q12852; -.
DR   BioGRID; 113566; 16.
DR   IntAct; Q12852; 9.
DR   MINT; Q12852; -.
DR   STRING; 9606.ENSP00000448689; -.
DR   BindingDB; Q12852; -.
DR   ChEMBL; CHEMBL1908389; -.
DR   DrugBank; DB12010; Fostamatinib.
DR   DrugCentral; Q12852; -.
DR   GuidetoPHARMACOLOGY; 2072; -.
DR   TCDB; 8.A.23.1.42; the basigin (basigin) family.
DR   iPTMnet; Q12852; -.
DR   PhosphoSitePlus; Q12852; -.
DR   SwissPalm; Q12852; -.
DR   BioMuta; MAP3K12; -.
DR   DMDM; 116242624; -.
DR   jPOST; Q12852; -.
DR   MassIVE; Q12852; -.
DR   PaxDb; Q12852; -.
DR   PeptideAtlas; Q12852; -.
DR   PRIDE; Q12852; -.
DR   ProteomicsDB; 32474; -.
DR   ProteomicsDB; 58985; -. [Q12852-1]
DR   Antibodypedia; 27132; 228 antibodies from 30 providers.
DR   DNASU; 7786; -.
DR   Ensembl; ENST00000267079.6; ENSP00000267079.2; ENSG00000139625.13. [Q12852-1]
DR   Ensembl; ENST00000547035.5; ENSP00000448689.1; ENSG00000139625.13. [Q12852-2]
DR   Ensembl; ENST00000547488.6; ENSP00000449038.1; ENSG00000139625.13. [Q12852-2]
DR   GeneID; 7786; -.
DR   KEGG; hsa:7786; -.
DR   MANE-Select; ENST00000547488.6; ENSP00000449038.1; NM_001193511.2; NP_001180440.1. [Q12852-2]
DR   UCSC; uc001sdm.3; human. [Q12852-1]
DR   CTD; 7786; -.
DR   DisGeNET; 7786; -.
DR   GeneCards; MAP3K12; -.
DR   HGNC; HGNC:6851; MAP3K12.
DR   HPA; ENSG00000139625; Low tissue specificity.
DR   MIM; 600447; gene.
DR   neXtProt; NX_Q12852; -.
DR   OpenTargets; ENSG00000139625; -.
DR   PharmGKB; PA30595; -.
DR   VEuPathDB; HostDB:ENSG00000139625; -.
DR   eggNOG; KOG4721; Eukaryota.
DR   GeneTree; ENSGT00940000159006; -.
DR   HOGENOM; CLU_009311_2_1_1; -.
DR   InParanoid; Q12852; -.
DR   OMA; PSAWEVC; -.
DR   OrthoDB; 938929at2759; -.
DR   PhylomeDB; Q12852; -.
DR   PathwayCommons; Q12852; -.
DR   SignaLink; Q12852; -.
DR   SIGNOR; Q12852; -.
DR   BioGRID-ORCS; 7786; 13 hits in 1103 CRISPR screens.
DR   ChiTaRS; MAP3K12; human.
DR   GeneWiki; MAP3K12; -.
DR   GenomeRNAi; 7786; -.
DR   Pharos; Q12852; Tchem.
DR   PRO; PR:Q12852; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   RNAct; Q12852; protein.
DR   Bgee; ENSG00000139625; Expressed in right hemisphere of cerebellum and 186 other tissues.
DR   ExpressionAtlas; Q12852; baseline and differential.
DR   Genevisible; Q12852; HS.
DR   GO; GO:0005737; C:cytoplasm; TAS:ProtInc.
DR   GO; GO:0005829; C:cytosol; ISS:UniProtKB.
DR   GO; GO:0030426; C:growth cone; IEA:Ensembl.
DR   GO; GO:0016020; C:membrane; ISS:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; ISS:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0004706; F:JUN kinase kinase kinase activity; IBA:GO_Central.
DR   GO; GO:0042803; F:protein homodimerization activity; ISS:UniProtKB.
DR   GO; GO:0004672; F:protein kinase activity; TAS:ProtInc.
DR   GO; GO:0019901; F:protein kinase binding; IPI:UniProtKB.
DR   GO; GO:0106310; F:protein serine kinase activity; IEA:RHEA.
DR   GO; GO:0043539; F:protein serine/threonine kinase activator activity; ISS:ARUK-UCL.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; ISS:UniProtKB.
DR   GO; GO:0035556; P:intracellular signal transduction; TAS:ProtInc.
DR   GO; GO:0007254; P:JNK cascade; ISS:UniProtKB.
DR   GO; GO:2000672; P:negative regulation of motor neuron apoptotic process; IEA:Ensembl.
DR   GO; GO:0018105; P:peptidyl-serine phosphorylation; ISS:ARUK-UCL.
DR   GO; GO:0018107; P:peptidyl-threonine phosphorylation; IEA:Ensembl.
DR   GO; GO:0045893; P:positive regulation of DNA-templated transcription; IMP:UniProtKB.
DR   GO; GO:0070374; P:positive regulation of ERK1 and ERK2 cascade; IMP:UniProtKB.
DR   GO; GO:0043507; P:positive regulation of JUN kinase activity; ISS:ARUK-UCL.
DR   GO; GO:0045860; P:positive regulation of protein kinase activity; ISS:ARUK-UCL.
DR   GO; GO:0043687; P:post-translational protein modification; ISS:UniProtKB.
DR   GO; GO:0046777; P:protein autophosphorylation; ISS:UniProtKB.
DR   GO; GO:0006468; P:protein phosphorylation; IDA:UniProtKB.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR017419; MAP3K12_MAP3K13.
DR   InterPro; IPR027257; MAPKKK12.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR001245; Ser-Thr/Tyr_kinase_cat_dom.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   Pfam; PF07714; PK_Tyr_Ser-Thr; 1.
DR   PIRSF; PIRSF500741; MAPKKK12; 1.
DR   PIRSF; PIRSF038165; MAPKKK12_MAPKKK13; 1.
DR   PRINTS; PR00109; TYRKINASE.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; ATP-binding; Cell membrane; Cytoplasm;
KW   Kinase; Magnesium; Membrane; Nucleotide-binding; Phosphoprotein;
KW   Reference proteome; Repeat; Serine/threonine-protein kinase; Transferase.
FT   CHAIN           1..859
FT                   /note="Mitogen-activated protein kinase kinase kinase 12"
FT                   /id="PRO_0000086261"
FT   DOMAIN          125..366
FT                   /note="Protein kinase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   REGION          51..73
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          390..411
FT                   /note="Leucine-zipper 1"
FT   REGION          443..464
FT                   /note="Leucine-zipper 2"
FT   REGION          524..587
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          613..859
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        731..778
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        802..816
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        236
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159,
FT                   ECO:0000255|PROSITE-ProRule:PRU10027"
FT   BINDING         131..139
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         152
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   MOD_RES         37
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q60700"
FT   MOD_RES         43
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q60700"
FT   MOD_RES         607
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q60700"
FT   MOD_RES         695
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q60700"
FT   VAR_SEQ         46
FT                   /note="H -> QCVLRDVVPLGGQGGGGPSPSPGGEPPPEPFANS (in isoform
FT                   2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_044646"
FT   VARIANT         409
FT                   /note="E -> K (in a breast pleomorphic lobular carcinoma
FT                   sample; somatic mutation)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040705"
FT   VARIANT         628
FT                   /note="G -> R (in dbSNP:rs34366500)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040706"
FT   VARIANT         640
FT                   /note="G -> S (in dbSNP:rs55794887)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040707"
FT   CONFLICT        355
FT                   /note="P -> S (in Ref. 3; BAG52841)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        498
FT                   /note="K -> N (in Ref. 1; AAA67343)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        504
FT                   /note="K -> Q (in Ref. 1; AAA67343)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        511
FT                   /note="T -> A (in Ref. 1; AAA67343)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        533
FT                   /note="G -> A (in Ref. 1; AAA67343)"
FT                   /evidence="ECO:0000305"
FT   HELIX           122..124
FT                   /evidence="ECO:0007829|PDB:5CEN"
FT   STRAND          126..134
FT                   /evidence="ECO:0007829|PDB:5CEN"
FT   STRAND          137..144
FT                   /evidence="ECO:0007829|PDB:5CEN"
FT   STRAND          147..153
FT                   /evidence="ECO:0007829|PDB:5CEN"
FT   HELIX           157..160
FT                   /evidence="ECO:0007829|PDB:5CEN"
FT   HELIX           163..165
FT                   /evidence="ECO:0007829|PDB:5CEN"
FT   STRAND          176..180
FT                   /evidence="ECO:0007829|PDB:5CEN"
FT   STRAND          187..191
FT                   /evidence="ECO:0007829|PDB:5CEN"
FT   HELIX           198..203
FT                   /evidence="ECO:0007829|PDB:5CEN"
FT   HELIX           210..229
FT                   /evidence="ECO:0007829|PDB:5CEN"
FT   HELIX           239..241
FT                   /evidence="ECO:0007829|PDB:5CEN"
FT   STRAND          242..244
FT                   /evidence="ECO:0007829|PDB:5CEN"
FT   STRAND          250..252
FT                   /evidence="ECO:0007829|PDB:5CEN"
FT   HELIX           264..271
FT                   /evidence="ECO:0007829|PDB:5CEN"
FT   HELIX           272..276
FT                   /evidence="ECO:0007829|PDB:5CEN"
FT   HELIX           279..282
FT                   /evidence="ECO:0007829|PDB:5CEN"
FT   HELIX           290..305
FT                   /evidence="ECO:0007829|PDB:5CEN"
FT   TURN            309..312
FT                   /evidence="ECO:0007829|PDB:5CEN"
FT   HELIX           315..323
FT                   /evidence="ECO:0007829|PDB:5CEN"
FT   HELIX           337..346
FT                   /evidence="ECO:0007829|PDB:5CEN"
FT   HELIX           351..353
FT                   /evidence="ECO:0007829|PDB:5CEN"
FT   HELIX           357..372
FT                   /evidence="ECO:0007829|PDB:5CEN"
FT   HELIX           376..396
FT                   /evidence="ECO:0007829|PDB:5CEN"
SQ   SEQUENCE   859 AA;  93219 MW;  1E1BCAD2F6DFCFE8 CRC64;
     MACLHETRTP SPSFGGFVST LSEASMRKLD PDTSDCTPEK DLTPTHVLQL HEQDAGGPGG
     AAGSPESRAS RVRADEVRLQ CQSGSGFLEG LFGCLRPVWT MIGKAYSTEH KQQQEDLWEV
     PFEEILDLQW VGSGAQGAVF LGRFHGEEVA VKKVRDLKET DIKHLRKLKH PNIITFKGVC
     TQAPCYCILM EFCAQGQLYE VLRAGRPVTP SLLVDWSMGI AGGMNYLHLH KIIHRDLKSP
     NMLITYDDVV KISDFGTSKE LSDKSTKMSF AGTVAWMAPE VIRNEPVSEK VDIWSFGVVL
     WELLTGEIPY KDVDSSAIIW GVGSNSLHLP VPSSCPDGFK ILLRQCWNSK PRNRPSFRQI
     LLHLDIASAD VLSTPQETYF KSQAEWREEV KLHFEKIKSE GTCLHRLEEE LVMRRREELR
     HALDIREHYE RKLERANNLY MELNALMLQL ELKERELLRR EQALERRCPG LLKPHPSRGL
     LHGNTMEKLI KKRNVPQKLS PHSKRPDILK TESLLPKLDA ALSGVGLPGC PKGPPSPGRS
     RRGKTRHRKA SAKGSCGDLP GLRTAVPPHE PGGPGSPGGL GGGPSAWEAC PPALRGLHHD
     LLLRKMSSSS PDLLSAALGS RGRGATGGAG DPGSPPPARG DTPPSEGSAP GSTSPDSPGG
     AKGEPPPPVG PGEGVGLLGT GREGTSGRGG SRAGSQHLTP AALLYRAAVT RSQKRGISSE
     EEEGEVDSEV ELTSSQRWPQ SLNMRQSLST FSSENPSDGE EGTASEPSPS GTPEVGSTNT
     DERPDERSDD MCSQGSEIPL DPPPSEVIPG PEPSSLPIPH QELLRERGPP NSEDSDCDST
     ELDNSNSVDA LRPPASLPP
//
